Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Adenovirus RIDalpha protein reveals novel autophagic mechanism that regulates cholesterol homeostasis.

Cianciola NL, Carlin CR.

Autophagy. 2010 Feb;6(2):296-8. Epub 2010 Feb 6. No abstract available.

PMID:
20139720
2.
3.

A multitasking oncolytic adenovirus vector.

Toth K, Doronin K, Tollefson AE, Wold WS.

Mol Ther. 2003 Apr;7(4):435-7. No abstract available.

4.

Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI.

Grant JR, Moise AR, Jefferies WA.

Clin Vaccine Immunol. 2007 Jul;14(7):907-17. Epub 2007 May 30.

5.
6.

Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region.

Toth K, Kuppuswamy M, Doronin K, Doronina O, Lichtenstein D, Tollefson A, Wold W.

Virology. 2002 Sep 15;301(1):99-108.

7.

Vironcology-not yet, but soon?

Vile RG.

Nat Biotechnol. 2001 Nov;19(11):1020-2. No abstract available.

PMID:
11689843
8.

Adenovirus death protein, a transmembrane protein encoded in the E3 region, is palmitoylated at the cytoplasmic tail.

Hausmann J, Ortmann D, Witt E, Veit M, Seidel W.

Virology. 1998 May 10;244(2):343-51.

9.

E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models.

Wang Y, Hallden G, Hill R, Anand A, Liu TC, Francis J, Brooks G, Lemoine N, Kirn D.

Nat Biotechnol. 2003 Nov;21(11):1328-35. Epub 2003 Oct 12.

PMID:
14555956
11.

Influence of E3 region on conditionally replicative adenovirus mediated cytotoxicity in hepatocellular carcinoma cells.

Lu Q, Yu DH, Fang C, Liu F, Ye X, Zhao Y, Qin J, Guo XK, Liang M, Hu F, Chen HZ.

Cancer Biol Ther. 2009 Jun;8(12):1125-32. Epub 2009 Jun 17.

PMID:
19448394
12.

Analysis of early region 1 of porcine adenovirus type 3.

Zhou Y, Tikoo SK.

Virology. 2001 Dec 5;291(1):68-76.

13.

The adenovirus E3-6.7K protein adopts diverse membrane topologies following posttranslational translocation.

Moise AR, Grant JR, Lippé R, Gabathuler R, Jefferies WA.

J Virol. 2004 Jan;78(1):454-63.

14.
16.
17.

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy.

Ramachandra M, Rahman A, Zou A, Vaillancourt M, Howe JA, Antelman D, Sugarman B, Demers GW, Engler H, Johnson D, Shabram P.

Nat Biotechnol. 2001 Nov;19(11):1035-41.

PMID:
11689848
19.

An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.

Catalucci D, Sporeno E, Cirillo A, Ciliberto G, Nicosia A, Colloca S.

J Virol. 2005 May;79(10):6400-9.

20.

Model systems for studying the effects of adenovirus E3 genes on virulence in vivo.

Horwitz MS, Tufariello J, Grunhaus A, Fejer G.

Curr Top Microbiol Immunol. 1995;199 ( Pt 3):195-211. Review. No abstract available.

PMID:
7555077

Supplemental Content

Support Center